Daily pill can double survival time for world’s deadliest cancer, trial shows

31 mai 2026 | Andrew Gregory in Chicago
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
 Site référencé:  The Guardian (Asia Pacific)

The Guardian (Asia Pacific) 

Trump administration proposes 25% tariffs on Brazil despite US trade surplus
2/06/2026
Spanish authorities cancel DR Congo v Chile World Cup warm-up over Ebola fears
2/06/2026
Jude Bellingham handed World Cup boost for England after being given No 10 shirt
2/06/2026
White House correspondents’ dinner rescheduled for July after shooting
2/06/2026
‘We don’t have another country to run to’ : Kenyans fear US plan for Ebola quarantine site
2/06/2026
Bazball comes full circle with a promise to ‘evolve slightly’ as New Zealand roll into town
2/06/2026